• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Providers

Latest News

Adverse Drug Reaction Warning | image credit: Balint Radu - stock.adobe.com
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy

May 9th 2024

A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.

Opdivo packaging | Image credit: Bristol Myers Squibb
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

May 9th 2024

MDS graphic | Image Credit: MdBabul-stock.adobe.com
Diagnostic Oversights Limit Luspatercept Benefits in MDS

May 8th 2024

Clinical research graphic | Image Credit: Karan - stock.adobe.com
Integrating RECIST and Clinician Approaches Boosts NSCLC Research

May 8th 2024

Heartbeats | Image credit: Robert - stock.adobe.com
Exercise-Induced Hypertension a Risk Factor for Sudden Cardiac Death, Review Finds

May 8th 2024

More News

© 2024 MJH Life Sciences
AJMC®
All rights reserved.